Zeman J, Hrebícek M, Vepreková L, Kytnarová J, Houstková H, Malinová V, Hodanová K, Poupĕtová H, Ledvinová J, Hoza J
Klinika dĕtského a dorostového lékarství 1. LF UK a VFN, Praha.
Cas Lek Cesk. 1997 Feb 5;136(3):95-7.
The enzyme therapy with Ceredase in patients with Gaucher's disease is at present probably the most expensive treatment in the whole world. One-year treatment of an adult patient with Gaucher's disease costs more than 7 million crowns. Indications for treatment in individual patients as well as financial provisions are so far problematic in the Czech Republic. From a total of 28 patients of varying age with Gaucher's disease diagnosed by the authors Ceredase was administered to two boys with a severe course of the disease. Within one year of treatment the health status of both children improved, growth became normal, the spleen diminished in size by 20-35%, haematological manifestations of hypersplenism are receding, there was a 32-46% decline of the activity of serum chitotriosidase and biochemical parameters of the disease improved.
目前,用思而赞对戈谢病患者进行酶疗法可能是全球最昂贵的治疗方法。成年戈谢病患者一年的治疗费用超过700万克朗。在捷克共和国,个体患者的治疗指征以及资金问题目前都存在困难。在作者诊断出的总共28例不同年龄段的戈谢病患者中,思而赞被用于两名病情严重的男孩。在治疗的一年内,两个孩子的健康状况都有所改善,生长恢复正常,脾脏大小缩小了20%至35%,脾功能亢进的血液学表现逐渐消退,血清壳三糖苷酶活性下降了32%至46%,疾病的生化指标也有所改善。